Graft-vs-Host Disease following Allogeneic Hematopoietic Cell Transplantation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Graft-vs-Host Disease following Allogeneic Hematopoietic Cell Transplantation
Authors
Keywords
-
Journal
Cancer Control
Volume 18, Issue 4, Pages 268-276
Publisher
SAGE Publications
Online
2017-08-30
DOI
10.1177/107327481101800407
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
- (2011) G. Socie et al. BLOOD
- A Randomized Phase II Trial Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate for Acute Graft-versus-Host Disease Prophylaxis
- (2010) Janelle Perkins et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Glucocorticoid-Refractory Acute Graft-versus-Host Disease
- (2010) Joseph Pidala et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Graft-versus-Host Disease Treatment: Predictors of Survival
- (2010) John E. Levine et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD
- (2010) Daniel Wolff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients
- (2010) Nishitha Reddy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
- (2010) J. R. Wingard et al. BLOOD
- Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis
- (2010) Mary Eapen et al. LANCET ONCOLOGY
- Sirolimus as Primary Treatment of Acute Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation
- (2009) Joseph Pidala et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Fludarabine-Melphalan Conditioning for AML and MDS: Alemtuzumab Reduces Acute and Chronic GVHD without Affecting Long-Term Outcomes
- (2009) Koen Van Besien et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impending Challenges in the Hematopoietic Stem Cell Transplantation Physician Workforce
- (2009) James L. Gajewski et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Improved Nonrelapse Mortality and Infection Rate with Lower Dose of Antithymocyte Globulin in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Transplantation for Hematologic Malignancies
- (2009) Mehdi Hamadani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Graft-versus-Host Disease Prophylaxis with Tacrolimus and Mycophenolate Mofetil in HLA-Matched Nonmyeloablative Transplant Recipients Is Associated with Very Low Incidence of GVHD and Nonrelapse Mortality
- (2009) Waleed Sabry et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Monitoring and Preemptive Rituximab Therapy for Epstein-Barr Virus Reactivation after Antithymocyte Globulin Containing Nonmyeloablative Conditioning for Umbilical Cord Blood Transplantation
- (2009) Anne H. Blaes et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
- (2009) J. Koreth et al. BLOOD
- Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
- (2009) A. M. Alousi et al. BLOOD
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- (2009) O. Landgren et al. BLOOD
- Quality of life after allogeneic hematopoietic cell transplantation
- (2009) J. Pidala et al. BLOOD
- A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens
- (2009) R. Rodriguez et al. BLOOD
- Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
- (2009) A. C. Vigorito et al. BLOOD
- New perspectives on the biology of acute GVHD
- (2009) S Paczesny et al. BONE MARROW TRANSPLANTATION
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
- (2009) Jürgen Finke et al. LANCET ONCOLOGY
- Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation
- (2009) Imran Ahmad et al. TRANSPLANTATION
- Comparison of Two Doses of Antithymocyte Globulin in Patients Undergoing Matched Unrelated Donor Allogeneic Stem Cell Transplantation
- (2008) Francis Ayuk et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A biomarker panel for acute graft-versus-host disease
- (2008) S. Paczesny et al. BLOOD
- New classification of chronic GVHD: added clarity from the consensus diagnoses
- (2008) M Arora et al. BONE MARROW TRANSPLANTATION
- Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors
- (2008) Francis Ayuk et al. EXPERIMENTAL HEMATOLOGY
- Feasibility of NIH consensus criteria for chronic graft-versus-host disease
- (2008) B-S Cho et al. LEUKEMIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started